期刊文献+

猕猴发育过程中肠肝组织血管活性肠肽及其受体的变化 被引量:1

Changes of vasoactive intestinal polypeptide and vasoactive intestinal polypeptide receptor 1 in small intestine and liver during macaque development
暂未订购
导出
摘要 本文旨在探讨猕猴发育过程中血管活性肠肽(vasoactive intestinal polypeptide,VIP)及其受体在肠肝组织的变化。通过手术途径获得胚胎6月、新生2 d、新生45 d和成年猕猴的回肠、肝脏、门静脉和外周血等标本,应用放射免疫分析法测定各标本中的VIP含量;通过免疫组化方法观察VIP在肠、肝组织内的分布;利用原位杂交法检测VIP受体1(VIP receptor 1,VIPR1)的表达。结果显示:(1)胚胎6月的猕猴小肠VIP含量为(20.7±14.3)ng/mg蛋白;小肠绒毛根部及黏膜下层可见少量的VIP阳性染色颗粒;在发育过程中,小肠VIP含量逐渐增加,成年期时达(514.8±49.2)ng/mg蛋白,较胚胎6月显著增加(P<0.01)。(2)成年猕猴小肠VIP主要分布于绒毛隐窝部、黏膜下层神经及环、纵行肌间神经丛及环行肌,在发育过程中相应部位的VIPR1表达逐渐上调。(3)肝脏在发育过程中VIP及VIPR1含量逐渐降低。(4)发育的各个时期,小肠组织的VIP含量均明显高于肝脏组织,门静脉VIP水平也始终高于外周血。结果提示,小肠绒毛隐窝部、黏膜下层神经及环、纵行肌间神经内VIP及VIPR1含量足在出生以后才迅速增加的;不论是在胚胎还是成年期,VIP均不在肝中代谢和分解,VIPR1仅见于胚胎肝脏血管。 The present study was aimed to investigate the changes of vasoactive intestinal polypeptide (VIP) and VIP receptor 1 (VIPR1) in small intestinal and hepatic tissues during macaque development. The tissue samples of small intestine, liver and blood samples from peripheral and portal vein of 4 macaques of 6-month fetus, 2-day neonate, 45-day neonate and adult were obtained after anesthetization. The concentration of VIP in blood or tissues of macaques was measured by radioimmunoassay. The distribution of VIP in small intestinal or hepatic tissues was visualized by immunohistochemical staining. The expression of VIPR1 was detected by in situ hybridization. The results showed that: (1) VIP concentration in intestinal tissue of 6-month fetus was (20.7±14.3) ng/mg protein, and a few VIP-positive nerve fibers first appeared in intestinal villus root and submucosal layer but not in muscle layer. The intestinal concentration of VIP increased gradually with macaque development and reached (514.8±49.2) ng/mg protein in adult, significantly higher than that in 6-month fetus (P〈0.01). (2) In adult animal, VIP-positive nerve fibers became thicker and gradually extended into the mucosal crypt, submucosal layer nerve, myenteric nerve plexus of annular muscle and indulge muscle, and annular muscle. Correspondingly, the expression of VIPR1 in intestine was up-regulated during development. (3) On the contrary, the levels of VIP and VIPR1 in liver were gradually decreased during development. (4) VIP concentration in small intestinal tissue was higher than that in hepatic tissue during development. The VIP level in portal vein was also significantly higher than that in peripheral blood during development. In conclusion, the levels of VIP and VIPR1 in mucosal crypt, submucosal layer nerve, myenteric nerve plexus of annular muscle and indulge muscle increase rapidly after birth. Most of VIP from intestinal tract is degraded in portal vein before entering liver, suggesting that VIP does not metabolize and decompose in liver, and that VIPR1 is only present in embryo hepatic blood vessels.
出处 《生理学报》 CAS CSCD 北大核心 2007年第2期163-168,共6页 Acta Physiologica Sinica
基金 This work was supported by the National Natural Science Foundation of China (No. 30571692).
关键词 血管活性肠肽 血管活性肠肽受体 发育 猕猴 小肠 肝脏 vasoactive intestinal polypeptide vasoactive intestinal polypeptide receptor development macaque small intestine liver
  • 相关文献

参考文献21

  • 1Said SI,Mutt V.Polypeptide with broad biological activity:isolation from small intestine.Science 1970; 169:1217-1218.
  • 2Van Geldre LA,Lefebvre RA.Interaction of NO and VIP in gastrointestinal smooth muscle relaxation.Curr Pharm Des 2004; 10:2483-2497.
  • 3Ferri GL,Adrian TE,Ghatei MA,O'Shaughnessy DJ,Probert L,Lee YC,Buchan AM,Polak JM,Bloom SR.Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel.Gastroenterology 1983;84:777-786.
  • 4Svoboda M,De Neef P,Tastenoy M,Christophe J.Molecular characteristics and evidence for internalization of vasoactiveintestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2.Eur J Biochem 1988; 176:707-713.
  • 5王利,唐承薇,王春晖,李献.发育过程中肝脏血管活性肠肽及其受体量的变化[J].生理学报,2005,57(3):379-383. 被引量:5
  • 6Schaffalitzky de Muckadell OB,Fahrenkrug J,Holst JJ,Laurritsen KB.Release of vasoactive intestinal polypeptide (VIP) by intra-duodenal stimuli.Scand J Gastroenterol 1977;12:793-799.
  • 7Ebeid AM,Escourrou J,Soeters PB,Murray P,Fischer JE.Hepatic inactivation of vasoactive intestinal peptide in man and dog.Ann Surg 1978; 188:28-33.
  • 8郭梅梅,谭庆华,范华,黄明慧,王春晖,丘小庆,唐承薇.猕猴发育过程中肠肝组织生长抑素及其受体表达演变规律[J].生理学报,2005,57(6):719-724. 被引量:13
  • 9Duggan KA,Jones DM,Davis RE,Macdonald GJ.Effect of neutral endopeptidase on plasma and tissue concentrations of vaso-active intestinal peptide.Clin Exp Pharmacol Physiol 1994; 21:307-309.
  • 10Laburthe M,Amiranoff B.Handbook of Physiology.1989,215-243.

二级参考文献51

共引文献26

同被引文献18

  • 1Vaudry H, Laburthe M. VIP, PACAP, and related peptides. From gene to therapy. Annu NY Acad Sci 2006; 1070: 631- 633.
  • 2Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SR, Sreedharan SP, Wank SA, Waschek JA. International Union of Pharmacology. XVⅢ. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 1998; 50: 265-270.
  • 3Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 2000; 52: 269-324.
  • 4Morley JE, Horowitz M, Morley PMK, Flood JF. Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice. Peptides 1992; 13:1133-1135.
  • 5Tachibana T, Saito S, Tomonaga S, Takagi T, Saito ES, Boswell T, Furuse M. Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in the chick. Neurosci Lett 2003; 339: 203-206.
  • 6Matsuda K, Maruyama K, Nakamachi T, Miura T, Uchiyama M, Shioda S. Inhibitory effects of pituitary adenylate cyclaseactivating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus. Peptides 2005; 26: 1611-1616.
  • 7Tachibana T, Saito S, Tomonaga S, Takagi T, Saito ES, Boswell T, Furuse M. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide inhibit feeding in the chick brain by different mechanisms. Neurosci Lett 2003; 348: 25-28.
  • 8Matsuda K, Maruyama K. Regulation of feeding behavior by pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in vertebrates. Peptides 2007; 28(9): 1761-1766.
  • 9Delgado MD, Pozo D, Ganea D. The significance of vasoacfive intestinal peptide in immunomodulafion. Pharmacol Rev 2004; 56: 249-290.
  • 10Gomariz RP, Juarranz Y, Abad C, Arranz A, Leceta J, Martinez C. VIP-PACAP system in immunity. Annu NY Acad Sci 2006; 1070:51-74.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部